SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
CEL-SCIAnnounces Results of Interim Review of Data From Its Ongoing Phase III Head and Neck Cancer Trial by Independent Data Monitoring Committee (IDMC)